Senior Managing Executive Officer Sonoda To Become President And Representative Director Effective April 1
26/02/2026 07:03
Feb 26 (Reuters) - JCR Pharmaceuticals Co Ltd 4552.T: SENIOR MANAGING EXECUTIVE OFFICER HIROYUKI SONODA TO BECOME PRESIDENT AND REPRESENTATIVE DIRECTOR EFFECTIVE APRIL 1 Source text: ID:nTSnz8b3dc Further company coverage: 4552.T
Recent news on JCR Pharmaceuticals
See all newsBrief: JCR Pharmaceuticals Receives Marketing Authorization In Kuwait For Izcargo
Italfarmaco And Jcr Pharmaceuticals Enter Into Exclusive License Agreement For Jr-141 In United States, Europe, And Latin America
Brief: Jcr Pharmaceuticals Receives Orphan Drug Designation For Givinostat In Japan
Brief: Medipal & JCR Dose First Patient In Global Phase I/II Trial OF JR-446 For Mucopolysaccharidosis Type IIIB
Table: Jcr Pharmaceuticals -Q1 group results